By contrast, HCV serum viral weight increased during the therapy in patient n
By contrast, HCV serum viral weight increased during the therapy in patient n. two individuals with type II combined cryoglobulinaemia syndrome associated with chronic HCV illness unresponsive to conventional treatments, including restorative plasmapheresis, who have been successfully treated with rituximab in our Haematology Unit. The rituximab treatment experienced a major medical impact in both of…
Read More “By contrast, HCV serum viral weight increased during the therapy in patient n” »